Prioritizing Medical Device Reimbursement During Product Development

Global Medical Device Podcast · 4 Feb 2021 · 40m · Episode 178

What this episode covers

Mike Drues of Vascular Sciences joins host John Spear to discuss the critical role of reimbursement strategy in medical device development. Drues explains how reimbursement incentives create disincentives for novel devices, leading to a market saturated with 'me-too' products, and advises integrating reimbursement planning early in the design phase. He highlights the financial advantages of the Breakthrough Device Program (BDP) and the importance of aligning regulatory and reimbursement strategies to maximize revenue.

Other shows on the same ground, closest first.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

  • Product Startup · 29m

    074: Medical Device Product Development Best Practices

    Rob Crowder, Head of Product at Nutromics, explains how his team uses user journey mapping to navigate the complexities of developing medical sensor devices, specifically the Neutromics wearable patch. He details the process of validating unmet needs in high-stakes areas like therapeutic drug monitoring for vancomycin, emphasizing the need to focus on specific indications like bacteremia to ensure clinical utility and commercial viability. Crowder contrasts this rigorous MedTech evidence bar with general product development, highlighting the importance of identifying all stakeholders—patients, clinicians, and payers—early in the design phase to avoid feature creep and resource burnout.

  • The Builder Circle · 1h 11m

    S2 E2: Demystifying Medical Device and System Development with Alan Cohen

    Alan Cohen, author of 'Prototype to Product' and a systems engineering manager specializing in radiation therapy devices, explains the complexities of medical device development to host Sera Evcimen. Cohen emphasizes that successful startups often emerge from collaborations between engineers and clinicians, and he details the critical importance of understanding reimbursement models, specifically CPT codes, before building a product. He advocates for using Fault Tree Analysis over FMEA for complex systems to manage risk efficiently and advises founders to balance lean documentation with rigorous process adherence to satisfy FDA requirements without over-engineering.

  • Let's Combinate · 26m

    176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski

    Eric Sugalski, founder and CTO of Archimedic, explains that the fastest way to ruin drug-device development is premature concept lock and misaligned outsourcing strategies. He argues that companies must distinguish between needing overflow capacity versus specialized expertise, such as human factors or industrial design, to avoid the 'piecemeal approach' that destroys innovation. Sugalski emphasizes the importance of early, hands-on user research and open-source quality management systems to bridge the gap between engineering and clinical reality, warning that locking down requirements before validating use cases injects costly redo loops into the project.

  • The Pragmatic Embedded Podcast · 37m

    Rapid Prototyping for Medical Devices with Ross Dehmoobed

    Ross Dehmoobed, VP of software and platforms at Veranex, explains how his company applies agile methodologies to medical device development. He details the use of 'Fusion Core' libraries and custom hardware modules to enable rapid prototyping, allowing teams to demonstrate functional breadboards and software features within the first two weeks. Dehmoobed emphasizes that while planning and regulatory pathway definition (such as 510(k) or de novo) require upfront waterfall-style rigor, the execution phase benefits from short sprints, off-target unit testing, and continuous customer feedback to maintain quality and speed.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.